株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生体イメージング用試薬の世界市場の予測

GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET FORECAST 2018-2026

発行 Inkwood Research 商品コード 557736
出版日 ページ情報 英文 145 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
生体イメージング用試薬の世界市場の予測 GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET FORECAST 2018-2026
出版日: 2018年08月27日 ページ情報: 英文 145 Pages
概要

当レポートでは、生体イメージング用試薬の世界市場について調査し、クラス・技術・エンドユーザー・応用分野・最終用途・地域別の市場動向および市場規模の予測、市場促進・阻害要因ならびに市場機会・課題の分析、市場の将来展望、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の決定要因

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第5章 市場区分

  • クラス別
    • コントラストイメージング試薬
    • 光学イメージング試薬
    • 核医学イメージング試薬
  • 技術別
    • 低分子化学品
    • プローブ
    • 放射性トレーサー
    • キレート分子
    • マイクロバブル
    • 蛍光タンパク質
    • ナノ粒子
  • エンドユーザー別
    • 診断機関
    • 研究開発機関
  • 応用分野別
    • コントラストイメージング
    • 光学イメージング
    • 放射線イメージング
  • 最終用途別
    • インビボイメージング
    • インビトロイメージング
  • モダリティ別
    • 光学
    • X線/CT
    • 核医学
    • MRI
    • 超音波

第6章 市場分析

  • ファイブフォース分析
  • パラメトリック分析
  • 主な購買基準

第7章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 企業プロファイル

  • BAYER HEALTHCARE
  • BECKMAN-COULTER
  • BRACCO
  • EVIDENT TECHNOLOGIES
  • GE HEALTHCARE
  • JUBILANT ORGANOSYS
  • LANTHEUS MEDICAL IMAGING
  • LIFE TECHNOLOGIES
  • PERKINELMER
  • SCHERING AG
  • SIEMENS MEDICAL

図表リスト

図表

LIST OF TABLES

  • TABLE 1: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 2: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY CLASS 2018-2026 ($ MILLION)
  • TABLE 3: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 4: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN MICROBUBBLES 2018-2026 ($ MILLION)
  • TABLE 5: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 6: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY APPLICATION 2018-2026 ($ MILLION)
  • TABLE 7: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN OPTICAL IMAGING 2018-2026 ($ MILLION)
  • TABLE 8: GLOBAL OPTICAL IMAGING MARKET IN INVITRO OPTICAL IMAGING 2018-2026 ($ MILLION)
  • TABLE 9: GLOBAL INVITRO OPTICAL IMAGING MARKET IN PROTEOMICS 2018-2026 ($ MILLION)
  • TABLE 10: GLOBAL INVITRO OPTICAL IMAGING MARKET IN GENOMICS 2018-2026 ($ MILLION)
  • TABLE 11: GLOBAL INVITRO OPTICAL IMAGING MARKET IN CELL BIOLOGY 2018-2026 ($ MILLION)
  • TABLE 12: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY END-USE 2018-2026 ($ MILLION)
  • TABLE 13: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY MODALITY 2018-2026 ($ MILLION)
  • TABLE 14: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN X-RAY/CT BY TYPE 2018-2026 ($ MILLION)
  • TABLE 15: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN X-RAY/CT BY INDICATION 2018-2026 ($ MILLION)
  • TABLE 16: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN NUCLEAR BY ISOTOPE 2018-2026 ($ MILLION)
  • TABLE 17: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN NUCLEAR BY INDICATION 2018-2026 ($ MILLION)
  • TABLE 18: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN NUCLEAR BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 19: GLOBAL NUCLEAR MARKET IN SPECT BY ISOTOPE 2018-2026 ($ MILLION)
  • TABLE 20: GLOBAL NUCLEAR MARKET IN SPECT BY INDICATION 2018-2026 ($ MILLION)
  • TABLE 21: GLOBAL NUCLEAR MARKET IN SPECT BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 22: GLOBAL NUCLEAR MARKET IN PET BY ISOTOPE 2018-2026 ($ MILLION)
  • TABLE 23: GLOBAL NUCLEAR MARKET IN PET BY INDICATION 2018-2026 ($ MILLION)
  • TABLE 24: GLOBAL NUCLEAR MARKET IN PET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 25: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 26: NORTH AMERICA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • TABLE 27: EUROPE BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • TABLE 28: ASIA PACIFIC BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • TABLE 29: REST OF THE WORLD BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 2: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN CONTRAST REAGENTS 2018-2026 ($ MILLION)
  • FIGURE 3: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN OPTICALREAGENTS 2018-2026 ($ MILLION)
  • FIGURE 4: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN NUCLEAR REAGENTS 2018-2026 ($ MILLION)
  • FIGURE 5: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN SMALL CHEMICALS 2018-2026 ($ MILLION)
  • FIGURE 6: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN PROBES 2018-2026 ($ MILLION)
  • FIGURE 7: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN RADIOTRACERS 2018-2026 ($ MILLION)
  • FIGURE 8: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN CHELATING MOLECULES 2018-2026 ($ MILLION)
  • FIGURE 9: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN MICRO BUBBLES 2018-2026 ($ MILLION)
  • FIGURE 10: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN FLUORESCENT PROTEINS 2018-2026 ($ MILLION)
  • FIGURE 11: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN NANOPARTICLES 2018-2026 ($ MILLION)
  • FIGURE 12: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN DIAGNOSTICS 2018-2026 ($ MILLION)
  • FIGURE 13: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN RESEARCH AND DEVELOPMENT 2018-2026 ($ MILLION)
  • FIGURE 14: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN CONTRAST IMAGING 2018-2026 ($ MILLION)
  • FIGURE 15: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN OPTICAL IMAGING 2018-2026 ($ MILLION)
  • FIGURE 16: GLOBAL OPTICAL IMAGING MARKET IN INVIVO 2018-2026 ($ MILLION)
  • FIGURE 17: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN RADIOACTIVE IMAGING 2018-2026 ($ MILLION)
  • FIGURE 18: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN IN-VIVO 2018-2026 ($ MILLION)
  • FIGURE 19: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN IN-VITRO 2018-2026 ($ MILLION)
  • FIGURE 20: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN OPTICAL 2018-2026 ($ MILLION)
  • FIGURE 21: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN X-RAY/CT 2018-2026 ($ MILLION)
  • FIGURE 22: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN NUCLEAR 2018-2026 ($ MILLION)
  • FIGURE 23: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN MRI 2018-2026 ($ MILLION)
  • FIGURE 24: GLOBAL BIOLOGICAL IMAGING REAGENTS MARKET IN ULTRASOUND 2018-2026 ($ MILLION)
  • FIGURE 25: PORTER'S FIVE FORCE MODEL OF BIOLOGICAL IMAGING REGENTS MARKET
  • FIGURE 26: BIOTECHNOLOGY FIRMS ACROSS COUNTRIES 2016
  • FIGURE 27: WORLDWIDE TOTAL PHARMACEUTICAL R&D EXPENDITURE 2015-2020 ($ BILLION)
  • FIGURE 28: KEY BUYING FACTORS OF BIOLOGICAL IMAGING REAGENTS 2018-2026
  • FIGURE 29: THE UNITED STATES BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 30: CANADA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 31: UNITED KINGDOM BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 32: FRANCE BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 33: MORTALITY RATE DUE TO CHRONIC DISEASES IN FRANCE
  • FIGURE 34: GERMANY BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 35: BIOTECHNOLOGY APPLICATIONS IN GERMANY
  • FIGURE 36: SPAIN BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 37: ITALY BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 38: REST OF EUROPE BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 39: CHINA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 40: INDIA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 41: JAPAN BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 42: APPLICATION OF JAPANESE BIOTECHNOLOGY
  • FIGURE 43: SOUTH KOREA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 44: AUSTRALIA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 45: REST OF ASIA PACIFIC BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 46: LATIN AMERICA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
  • FIGURE 47: MIDDLE EAST AND AFRICA BIOLOGICAL IMAGING REAGENTS MARKET 2018-2026 ($ MILLION)
目次
Product Code: 9479

KEY FINDINGS:

The Global biological imaging reagent market is predicted to rise at a CAGR of 7.86% over the forecast period of 2018- 2026. The key factors driving market growth include the growing demand for imaging technologies, innovations for novel targeted imaging agents and imaging technologies, and the ease of accessibility for the pioneering laser eye medication.

MARKET INSIGHTS:

The global biological imaging reagent market is segmented based on the technology, modalities, end-users, class, end-use, and applications. The technological segment comprises of probes, small chemicals, radiotracers, microbubbles, chelating molecules, fluorescent proteins, and nanoparticles. The market by modality is segmented into nuclear, optical, MRI, X-ray/CT, and ultrasound. The end-users for this market mainly comprise of diagnostics and research developments institutes. The market segment by class is further categorized according to the optical reagents, contrast reagents, and nuclear reagents. The end-use for the market can be used for in-vitro and in-vivo methodologies whereas the applications can be seen in contrast imaging, radioactive imaging, and optical imaging.

REGIONAL INSIGHTS:

The global biological imaging market is geographically spread throughout North America, Asia-Pacific, Europe and the rest of the world. Of these, the North American region dominated the global market in 2017, with the United States accounting for the highest market share. This remarkable growth in the US can be credited to the increasing government funding for life science-based research, growing demand for GMO crops, and the booming pharmaceutical industry in the region. Over the forecast period, it is the rest of the world market (that comprises of countries like the Middle East, Africa, and Latin America) which is likely to be the fastest growing region for the global market.

COMPETITIVE INSIGHTS:

PerkinElmer is a noted company in the market that provides products, services, and solutions focused on improving the health and safety of the people. Another important company, Bayer HealthCare Pharmaceuticals, is highly focused on developing and marketing therapeutic medicines for areas like oncology, gynaecology, cardiology, ophthalmology, and haematology. The company operates in over 100 countries around the world. Some of the other well-known market players include Beckman-Coulter, Evident Technologies, Schering Ag, Bracco, GE Healthcare, Lantheus Medical Imaging, Jubilant Organosys, Life Technologies, and Siemens Medical.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. HIGH MARKET GROWTH RATE FOR NUCLEAR IMAGING REAGENTS BY CLASS
    • 3.2.2. SPECT AND PET IMAGING REAGENT IS A RAPIDLY GROWING SEGMENT FOR THE PHARMACEUTICAL INDUSTRY
    • 3.2.3. RESEARCH AND DEVELOPMENT IS THE FASTEST GROWING END-USER SEGMENT

4. MARKET DETERMINANTS

  • 4.1. DRIVERS
    • 4.1.1. INCREASE IN THE DEMAND FOR IMAGING TECHNOLOGIES
    • 4.1.2. INCREASED ACCESSIBILITY TO CUTTING EDGE LASER EYE MEDICATION
    • 4.1.3. DEVELOPMENT OF NEWER, TARGETED IMAGING AGENTS AND EXPANSION OF IMAGING TECHNOLOGIES
  • 4.2. RESTRAINTS
    • 4.2.1. TECHNOLOGICAL AND SCIENTIFIC ADVANCES INCREASES THE COST OF REAGENTS
    • 4.2.2. NEED FOR LESS TOXIC/HAZARDOUS REAGENTS
  • 4.3. OPPORTUNITIES
    • 4.3.1. RESEARCH IN ENVIRONMENTAL BIOTECHNOLOGY
    • 4.3.2. DEVELOPMENT OF PIVOTAL INNOVATIONS
  • 4.4. CHALLENGES
    • 4.4.1. DIFFERENCES IN REGULATIONS

5. MARKET SEGMENTATION

  • 5.1. MARKET BY CLASS 2018-2026
    • 5.1.1. CONTRAST REAGENTS
    • 5.1.2. OPTICAL REAGENTS
    • 5.1.3. NUCLEAR REAGENTS
  • 5.2. MARKET BY TECHNOLOGY 2018-2026
    • 5.2.1. SMALL CHEMICALS
    • 5.2.2. PROBES
    • 5.2.3. RADIOTRACERS
    • 5.2.4. CHELATING MOLECULES
    • 5.2.5. MICROBUBBLES
    • 5.2.6. FLUORESCENT PROTEINS
    • 5.2.7. NANOPARTICLES
  • 5.3. MARKET BY END USER 2018-2026
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. RESEARCH AND DEVELOPMENT
  • 5.4. MARKET BY APPLICATION 2018-2026
    • 5.4.1. CONTRAST IMAGING
    • 5.4.2. OPTICAL IMAGING
      • 5.4.2.1. IN-VITRO
      • 5.4.2.1.1. PROTEOMICS
      • 5.4.2.1.2. GENOMICS
      • 5.4.2.1.3. CELL BIOLOGY
      • 5.4.2.2. IN-VIVO
    • 5.4.3. RADIOACTIVE IMAGING
  • 5.5. MARKET BY END-USE 2018-2026
    • 5.5.1. IN-VIVO
    • 5.5.2. IN-VITRO
  • 5.6. MARKET BY MODALITY 2018-2026
    • 5.6.1. OPTICAL
    • 5.6.2. X-RAY/CT
    • 5.6.3. NUCLEAR
      • 5.6.3.1. SPECT
      • 5.6.3.2. PET
    • 5.6.4. MRI
    • 5.6.5. ULTRASOUND

6. KEY ANALYTICAL

  • 6.1. PORTER'S FIVE FORCE MODEL
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTE PRODUCT OR SERVICES
    • 6.1.3. BARGAINING POWER OF BUYER
    • 6.1.4. BARGAINING POWER OF SUPPLIER
    • 6.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.2. PARAMETRIC ANALYSIS
  • 6.3. BIOTECHNOLOGY FIRMS ACROSS COUNTRIES
    • 6.3.1. GLOBAL PHARMACEUTICAL RESEARCH & DEVELOPMENT EXPENDITURE
  • 6.4. KEY BUYING CRITERIA
    • 6.4.1. SUSTAINABILITY
    • 6.4.2. QUALITY OF PRODUCT
    • 6.4.3. COST
    • 6.4.4. AVAILABILITY
  • 6.5. REGULATORY FRAMEWORK
    • 6.5.1. REGULATIONS IN NORTH AMERICA
    • 6.5.2. REGULATIONS IN EUROPE
    • 6.5.3. REGULATIONS IN ASIA PACIFIC

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. ITALY
    • 7.2.6. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. INDIA
    • 7.3.3. JAPAN
    • 7.3.4. SOUTH KOREA
    • 7.3.5. AUSTRALIA
    • 7.3.6. REST OF ASIA PACIFIC
  • 7.4. REST OF THE WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST AND AFRICA (MEA)

8. COMPANY PROFILES

  • 8.1. BAYER HEALTHCARE PHARMACEUTICALS
    • 8.1.1. COMPANY OVERVIEW
    • 8.1.2. PRODUCTS PORTFOLIO
    • 8.1.3. SWOT ANALYSIS
    • 8.1.4. STRATEGIC INITIATIVES
  • 8.2. BECKMAN COULTER GMBH
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCTS PORTFOLIO
    • 8.2.3. SWOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. BIO-RAD LABORATORIES INC.
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. SCOT ANALYSIS
    • 8.3.3. STRATEGIC INITIATIVES
  • 8.4. BRACCO SPA
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCTS PORTFOLIO
    • 8.4.3. SWOT ANALYSIS
    • 8.4.4. STRATEGIC INITIATIVES
  • 8.5. GE HEALTHCARE
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCTS PORTFOLIO
    • 8.5.3. SWOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. JUBILANT LIFE SCIENCE
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCTS PORTFOLIO
    • 8.6.3. SWOT ANALYSIS
    • 8.6.4. STRATEGIC INITIATIVES
  • 8.7. LANTHEUS MEDICAL IMAGING INC
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCTS PORTFOLIO
    • 8.7.3. SWOT ANALYSIS
    • 8.7.4. STRATEGIC INITIATIVES
  • 8.8. LIFE TECHNOLOGIES (ACQUIRED BY THERMO FISHER)
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCTS PORTFOLIO
    • 8.8.3. SWOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. PERKINELMER, INC.
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCTS PORTFOLIO
    • 8.9.3. SWOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVES
  • 8.10. SIEMENS MEDICAL SOLUTIONS USA INC
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCTS PORTFOLIO
    • 8.10.3. SWOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVES
Back to Top